Total trials
165
Active
0
Phase 3
77
Total enrollment
337,891
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Meningococcal Disease34
- Influenza30
- Meningococcal Meningitis22
- Seasonal Influenza10
- Human Influenza7
- Meningococcal Infections6
- Rabies5
- Pandemic Influenza4
Frequently asked questions about Novartis Vaccines
- How many clinical trials does Novartis Vaccines have on ClinicalTrials.gov?
- Novartis Vaccines is listed as the lead sponsor on 165 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Novartis Vaccines's trials are in Phase 3?
- 77 of Novartis Vaccines's trials are in Phase 3.
- What therapeutic areas does Novartis Vaccines focus on?
- Novartis Vaccines's most-studied conditions on ClinicalTrials.gov are Meningococcal Disease, Influenza, Meningococcal Meningitis, Seasonal Influenza, Human Influenza.